<DOC>
	<DOCNO>NCT00408382</DOCNO>
	<brief_summary>To evaluate efficacy intensive lipid-lowering therapy Lipitor change characteristic yellow coronary plaque subject hypercholesteremia accompany coronary artery disease</brief_summary>
	<brief_title>Lipitor Phase 4 Clinical Trial Hypercholesteremia Patients With Yellow Coronary Plaque</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patients hypercholesteremia The indication coronary angiography , coronary angioscopy intravascular ultrasound expect Patients current administration Lipitor history discontinue administration Lipitor Acute cardiac infarction</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Lipitor</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>Hypercholesteremia</keyword>
	<keyword>yellow coronary plaque</keyword>
</DOC>